VTVT
vTv Therapeutics Inc
NASDAQ: VTVT · HEALTHCARE · BIOTECHNOLOGY
$32.24
+3.10% today
Updated 2026-04-30
Market cap
$125.92M
P/E ratio
—
P/S ratio
14,852.65x
EPS (TTM)
$-3.20
Dividend yield
—
52W range
$14 – $44
Volume
0.1M
vTv Therapeutics Inc (VTVT) Financial statements
SEC filings — annual and quarterly data.
Profit margin
0.00%
Operating margin
0.00%
ROE
-78.90%
ROA
-32.00%
Debt/equity
—
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2013 | $976000.00 | $-48.20M | -2,505.94% | -3,671.41% | -4,938.83% |
| 2014 | $1.55M | $-36.10M | -1,109.10% | -1,865.53% | -2,330.60% |
| 2015 | $519000.00 | $-27.50M | 100.00% | -7,349.13% | -5,298.27% |
| 2016 | $634000.00 | $-16.35M | -7,115.77% | -8,678.23% | -2,579.18% |
| 2017 | $291000.00 | $-16.14M | -13,521.99% | -17,416.49% | -5,547.77% |
| 2018 | $12.43M | $-7.91M | -85.26% | -159.43% | -63.62% |
| 2019 | $2.76M | $-21.94M | -447.00% | -755.86% | -793.70% |
| 2020 | $6.41M | $-8.50M | -71.73% | -184.78% | -132.51% |
| 2021 | $4.00M | $-12.99M | 100.00% | -540.87% | -324.27% |
| 2022 | $2.02M | $-19.16M | 100.00% | -1,116.95% | -949.65% |
| 2023 | $9000.00 | $-20.25M | -1,000.00% | -283,355.56% | -225,000.00% |
| 2024 | $1.02M | $-18.46M | 100.00% | -2,377.58% | -1,815.34% |
| 2025 | $0.00 | $-26.97M | — | — | — |